PanTher Therapeutics
PrivateLast Round
Grant
May 20, 2026
Total Funding Raised
$38.3M
Company Overview
PanTher Therapeutics is a clinical-stage oncology company that develops a proprietary platform for continuous, high-dose, localized treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanTher Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PanTher Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2026 | ||||
| Series B | Apr 4, 2025 | ||||
| Convertible Debt | Dec 18, 2023 | ||||
| Series A Extension | Dec 16, 2022 | ||||
| Grant | Aug 17, 2022 | ||||
Series A Extension | Jun 24, 2022 |
PanTher Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention & Research Institute of Texas | Grant |
| MedTech Innovator | Grant |
| Massachusetts Life Sciences Center | Grant |
| Catalyst Health Ventures | Series A Extension, Series A, Series B |
| Angel Physicians Fund | Series A, Series A Extension, Series B |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2022
Received $14.3M grant from the Cancer Prevention & Research Institute of Texas.
PanTher Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PanTher Therapeutics's valuation, stock price, and market status.